DEPOMED INC 4
4 · DEPOMED INC · Filed Feb 23, 2017
Insider Transaction Report
Form 4
DEPOMED INCDEPO
Zenoff David B
Director
Transactions
- Exercise/Conversion
Common Stock
2017-02-21$3.27/sh+15,000$49,050→ 63,999 total(indirect: By Trust) - Exercise/Conversion
Common Stock
2017-02-21$1.49/sh+15,000$22,350→ 78,999 total(indirect: By Trust) - Exercise/Conversion
Common Stock
2017-02-21$3.45/sh+15,000$51,750→ 93,999 total(indirect: By Trust) - Exercise/Conversion
Common Stock
2017-02-21+15,000→ 0 totalExercise: $1.49Exp: 2018-12-09→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2017-02-21+15,000→ 0 totalExercise: $3.27Exp: 2017-12-06→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2017-02-21$3.59/sh+25,000$89,750→ 48,999 total(indirect: By Trust) - Exercise/Conversion
Common Stock
2017-02-21+15,000→ 0 totalExercise: $3.45Exp: 2019-12-07→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2017-02-21+25,000→ 0 totalExercise: $3.59Exp: 2017-03-21→ Common Stock (25,000 underlying)
Footnotes (4)
- [F1]25,000 Stock Options were granted on March 21, 2007 and were exercisable in 48 equal monthly installments. The Stock Options exercised on February 21, 2017 were Non-Qualified Stock Options (NSOs).
- [F2]15,000 Stock Options were granted on December 6, 2007 and were exercisable in 12 equal monthly installments. The Stock Options exercised on February 21, 2017 were Non-Qualified Stock Options (NSOs).
- [F3]15,000 Stock Options were granted on December 9, 2008 and were exercisable in 12 equal monthly installments. The Stock Options exercised on February 21, 2017 were Non-Qualified Stock Options (NSOs).
- [F4]15,000 Stock Options were granted on December 7, 2009 and were exercisable in 12 equal monthly installments. The Stock Options exercised on February 21, 2017 were Non-Qualified Stock Options (NSOs).